Lexatumumab

Cat. No.: IBDI-431969

Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research.

Product Details

Target	Apoptosis
Molecular Weight	143.6
Synonyms	HGS-ETR 2, ETR2-ST01, Anti-Human ERBB3 Recombinant Antibody
SMILES	[Lexatumumab]

Storage & Handling

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.